Nanoparticle-Reduced Sucrose for Biopharmaceutical Formulations
Nov 04 2019 Read 396 Times
Merck developed a new filtration-based manufacturing process resulting in a new, highly purified sucrose grade with reduced levels of nanoparticle impurities (NPI). The new product, Sucrose EMPROVE® EXPERT Ph Eur, ChP, JP, NF, is the ideal choice for the high-risk applications of manufacturing and formulating biomolecules.
As a widely used protein stabiliser for biomolecule formulation, the quality of sucrose is crucial. In an exclusive collaboration with Coriolis Pharma, Merck designed the new purification process and associated nanoparticle analytics of sucrose. The result is a highly pure sucrose that offers the following benefits over non-purified sucrose: a low level of NPIs on the limit of detection of current technologies, reducing the risk for protein instability; less interference with analytical methods; high batch-to-batch consistency; reduced risk of API damage.
Sucrose EMPROVE® EXPERT Ph Eur, ChP, JP, NF is part of Merck’s broad portfolio of protein stabilising excipients including trehalose, mannitol, sorbitol and glycine. The new offering is part of the company’s Emprove® Program, which facilitates drug product manufacturers’ risk assessment workflows and supplier qualification.
More information online: https://ilmt.co/PL/ODOy
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Ambient Ionisation MS and GC-MS Analysis and Identification of Aroma Compounds in Agave Based Alcoholic Beverages - How a Chromatographic Method is More Than a Sep...
View all digital editions
Sep 29 2020 Utrecht, Holland
Oct 06 2020 Lagos, Nigeria
Oct 06 2020 Digital Forum
Oct 07 2020 Lyon, France
Oct 07 2020 Lausanne, Switzerland